CDK2 and malignant colon neoplasm: In our study, we found that NPTX1 inhibits cell proliferation by inducing cell cycle arrest and down-regulating cycle-related proteins (Cyclin A2 and CDK2), these findings are consistent with findings in colon cancer [12].